홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Sodium hydride → 4-(4-Chloro-2-fluoroanilino)-7-(2-(2,6-dioxopiperidino)ethoxy)-6-methoxyquinazoline

HRID 1838565
인쇄

반응식

HRID 1838565 반응식
[H-].[Na+].[C:3]1(=[O:10])[NH:8][C:7](=[O:9])[CH2:6][CH2:5][CH2:4]1.Br[CH2:12][CH2:13][O:14][C:15]1[CH:24]=[C:23]2[C:18]([C:19]([NH:25][C:26]3[CH:31]=[CH:30][C:29]([Cl:32])=[CH:28][C:27]=3[F:33])=[N:20][CH:21]=[N:22]2)=[CH:17][C:16]=1[O:34][CH3:35]>CN(C=O)C>[Cl:32][C:29]1[CH:30]=[CH:31][C:26]([NH:25][C:19]2[C:18]3[C:23](=[CH:24][C:15]([O:14][CH2:13][CH2:12][N:8]4[C:7](=[O:9])[CH2:6][CH2:5][CH2:4][C:3]4=[O:10])=[C:16]([O:34][CH3:35])[CH:17]=3)[N:22]=[CH:21][N:20]=2)=[C:27]([F:33])[CH:28]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 3

HCID 24758Sodium hydrideHCID 70726GlutarimideHCID 187534227-(2-Bromoethoxy)-4-(4-chloro-2-fluoroanilino)6-methoxyquinazoline

생성물 1

HCID 224782274-(4-Chloro-2-fluoroanilino)-7-(2-(2,6-dioxopiperidino)ethoxy)-6-methoxyquinazoline수율 55%

시약·촉매·용매 1

HCID 6228Dimethylformamide용매2회

실험 절차

Sodium hydride (55 mg of a 60% dispersion in mineral oil. 1.1 mmol) was added to a solution of glutarimide (120 mg, 1.06 mmol) in DMF (5 ml) at ambient temperature under argon and the mixture stirred for 30 minutes. 7-(2-Bromoethoxy)-4-(4-chloro-2-fluoroanilino)-6-methoxyquinazoline (428 mg, 1 mmol), (prepared as described for the starting material in Example 62), in DMF (2 ml) was added and the resulting pale green solution was stirred for 18 hours and then quenched with water. The volatiles were removed by evaporation, and the residue was partitioned between water and ethyl acetate. The organic phase was separated and washed with water and then dried (MgSO4). The solvent was removed by evaporation, and the residue was purified by column chromatography eluting with ethyl acetate then ethyl acetate/methanol (9/1). The purified product was recrystallised from ethyl acetate and hexane, collected by filtration and washed with ether to give 4-(4-chloro-2-fluoroanilino)-7-(2-(2,6-dioxopiperidino)ethoxy)-6-methoxyquinazoline (252 mg, 55%).

후처리

  1. additionwas added
  2. stirringthe resulting pale green solution was stirred for 18 hours
  3. customquenched with water
  4. customThe volatiles were removed by evaporation
  5. customthe residue was partitioned between water and ethyl acetate
  6. customThe organic phase was separated
  7. washwashed with water
  8. dry with materialdried (MgSO4)
  9. customThe solvent was removed by evaporation
  10. customthe residue was purified by column chromatography
  11. washeluting with ethyl acetate
  12. customThe purified product was recrystallised from ethyl acetate and hexane
  13. filtrationcollected by filtration
  14. washwashed with ether

출처 및 근거

ORD 기록
ord-79ff2895d009484aacfb38dd24969eaa
출처 데이터셋
uspto-grants-2004_01
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06673803B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트